Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP981182.RApr9ntl-0eB0Xo2859a4S1V3eUw2Y8QsLyg25HsaJA6s130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP981182.RApr9ntl-0eB0Xo2859a4S1V3eUw2Y8QsLyg25HsaJA6s130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP981182.RApr9ntl-0eB0Xo2859a4S1V3eUw2Y8QsLyg25HsaJA6s130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP981182.RApr9ntl-0eB0Xo2859a4S1V3eUw2Y8QsLyg25HsaJA6s130_provenance.
- befree-2016 importedOn "2016-02-19" NP981182.RApr9ntl-0eB0Xo2859a4S1V3eUw2Y8QsLyg25HsaJA6s130_provenance.
- NP981182.RApr9ntl-0eB0Xo2859a4S1V3eUw2Y8QsLyg25HsaJA6s130_assertion wasGeneratedBy ECO_0000203 NP981182.RApr9ntl-0eB0Xo2859a4S1V3eUw2Y8QsLyg25HsaJA6s130_provenance.
- NP981182.RApr9ntl-0eB0Xo2859a4S1V3eUw2Y8QsLyg25HsaJA6s130_assertion wasDerivedFrom befree-2016 NP981182.RApr9ntl-0eB0Xo2859a4S1V3eUw2Y8QsLyg25HsaJA6s130_provenance.
- NP981182.RApr9ntl-0eB0Xo2859a4S1V3eUw2Y8QsLyg25HsaJA6s130_assertion SIO_000772 22576344 NP981182.RApr9ntl-0eB0Xo2859a4S1V3eUw2Y8QsLyg25HsaJA6s130_provenance.
- NP981182.RApr9ntl-0eB0Xo2859a4S1V3eUw2Y8QsLyg25HsaJA6s130_assertion evidence source_evidence_literature NP981182.RApr9ntl-0eB0Xo2859a4S1V3eUw2Y8QsLyg25HsaJA6s130_provenance.
- NP981182.RApr9ntl-0eB0Xo2859a4S1V3eUw2Y8QsLyg25HsaJA6s130_assertion description "[In the present study, we tested the utility of mouse CMV (mCMV)-based vaccines expressing human prostate-specific antigen (PSA) for prostate cancer immunotherapy in double-transgenic mice expressing PSA and HLA-DRB1*1501 (DR2bxPSA F1 mice).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP981182.RApr9ntl-0eB0Xo2859a4S1V3eUw2Y8QsLyg25HsaJA6s130_provenance.